Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
11.89
-0.48 (-3.88%)
Mar 31, 2025, 1:29 PM EDT - Market open
Zymeworks Employees
As of December 31, 2024, Zymeworks had 286 total employees, including 280 full-time and 6 part-time employees. The number of employees increased by 8 or 2.88% compared to the previous year.
Employees
286
Change (1Y)
8
Growth (1Y)
2.88%
Revenue / Employee
$266,797
Profits / Employee
-$429,003
Market Cap
827.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ZYME News
- 5 days ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 5 days ago - Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting - GlobeNewsWire
- 24 days ago - Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251 - Benzinga
- 25 days ago - Zymeworks Inc. (ZYME) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration - GlobeNewsWire
- 5 weeks ago - Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors - GlobeNewsWire
- 6 weeks ago - Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025 - GlobeNewsWire